Bhadresh Patel, our Chief Operating Officer, and Jenn Ryu, our Chief Financial Officer, are with me today to discuss Q1 ...

Q1 2026 Earnings Call April 9, 2026 9:00 AM EDTCompany ParticipantsConn Davis - CEO & DirectorLaurilee Kearnes - ...

Levi Strauss & Co. (NYSE:LEVI) Q1 2026 Earnings Call Transcript April 7, 2026 Levi Strauss & Co. beats earnings expectations.

Bile Acid Medicines Sales -- $41 million attributed to CHOLBAM and CTEXLI medicines supported by expanded CTX patient finding ...

Q2 2026 Earnings Call April 9, 2026 12:00 PM EDTCompany ParticipantsGualberto Hernandez - Executive VP & CFODavid Price - ...

Dave & Buster’s Entertainment, Inc. (NASDAQ:PLAY) Q4 2026 Earnings Call Transcript March 31, 2026 Dave & Buster’s Entertainment, Inc. misses on earnings expectations. Reported EPS is $-0.35 EPS, ...

CTEXLI approved by FDA for CTX; LIVMARLI approved in Japan for PFIC and Alagille syndrome with partner Takeda; and a single ...

First, this was another outstanding quarter for AAR. Total sales increase included 14% organic adjusted sales growth led by ...

Since I stepped into the President’s role in June 2025, our focus has been very clear: to accelerate Dyadic International, Inc.’s transition from a development-stage platform company into a commercial ...

GEN Restaurant Group, Inc. (NASDAQ:GENK) Q4 2025 Earnings Call Transcript March 31, 2026 GEN Restaurant Group, Inc. misses on ...

Origin Materials, Inc. (NASDAQ:ORGN) Q4 2025 Earnings Call Transcript March 27, 2026 Origin Materials, Inc. misses on ...

Cespira Revenue -- $12 million, compared to $4.1 million, with prior-period results representing only one month of Cespira ...